You must have Credits on your Balance to download this sample
Does lupron provide a better outcome for first line treatment in advanced prostate cancer
Finance & Accounting
Pages 21 (5271 words)
Evaluation of Luprolide (Lupron) as a First-Line Medical ADT Intervention in the Treatment of Advanced Prostate Cancer: A Measure of Outcomes Over 6 Months, One Year, Two Years, Five Years, and Ten Years. Outline Introduction Prostate cancer as a continuing challenge to modern medical science The threat of prostate cancer in the U.S.A Literature Review Development of prostate cancer Risk factors associated with prostate cancer Pathophysiology Survival and proliferation of prostate cancer cells Medical management of prostate cancer Androgen deprivation therapy Androgen deprivation therapy agents Castration-resistant prostate cancer (CRPC).
Introduction In spite of all the dramatic advances in the understanding of disease processes, medical science and medical technologies, cancer remains a disease of special focus in present times, because of the challenges that it continues to pose as a life threatening disease. Most of the cancer diseases tend to be chronic, with a strong possibility of causing the death of the individual, yet take years to develop, before presenting any signs and symptoms of the disease. There is limited clarity in how cancer diseases develop and the exact etiology of most cancers is yet to be clearly defined. Treatment of many cancers involves employing repeated interventions and multiple approaches at the different stages of the disease. ...
Not exactly what you need?